Risks of incorrect dosing of oral anti-cancer medicines (23rd January 2008)
The National Patient Safety Agency (NPSA) is alerting all healthcare staff involved in the use of oral anti-cancer medicines of potentially fatal outcomes if incorrect doses of these medicines are used. These oral anti-cancer medicines are increasingly being used in hospitals and in the community. Risks are increased if non-specialist practitioners prescribe, dispense or administer these oral medicines and bypass the normal safeguards used for injectable anti-cancer medicines.
Click here for the Rapid Response Report
Click here for Additional Information
The National Patient Safety Agency (NPSA) is alerting all healthcare staff involved in the use of oral anti-cancer medicines of potentially fatal outcomes if incorrect doses of these medicines are used. These oral anti-cancer medicines are increasingly being used in hospitals and in the community. Risks are increased if non-specialist practitioners prescribe, dispense or administer these oral medicines and bypass the normal safeguards used for injectable anti-cancer medicines.
Click here for the Rapid Response Report
Click here for Additional Information
No comments:
Post a Comment